Jason Tardio

Profile Overview

Jason Tardio is a highly experienced and innovative executive in the pharmaceutical industry. He is currently the President and Chief Operating Officer at Immunic Therapeutics, based in Cambridge, Massachusetts. Immunic Therapeutics focuses on the development of selective oral immunology therapies for chronic inflammatory and autoimmune diseases such as multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis.

Educational Background

Jason's educational background includes a Bachelor of Science in Exercise Science from The College of New Jersey, followed by a Master of Business Administration specializing in Pharmaceutical Marketing from Saint Joseph's University. This strong academic foundation provided him with both technical knowledge and business acumen, which he has successfully applied throughout his career.

Career Trajectory

Jason's career trajectory is marked by a series of significant roles spanning various companies and functions. He began as a Sales Representative at Wyeth Ayerst Laboratories in New York, moving to Sepracor Inc, where he held various sales, marketing, and training positions. His journey with Biogen started in 2009 as an Area Business Manager in Boston. Over the years, he held multiple leadership roles, such as Senior Product Manager for the AVONEX US Commercial Marketing Team, Director positions within the PLEGRIDY and DEXPRAMIPEXOLE marketing teams, and Head of Commercial activities for Biogen's Latin American operations.

Biogen Leadership Roles

In June 2017, Jason became the General Manager and Managing Director for Biogen Latin America South, overseeing operations in Argentina, Chile, and Uruguay, ensuring profitability and strategic alignment. He later joined Novartis in 2018, ascending to Vice President roles, where he significantly impacted the Multiple Sclerosis business unit and its sales organization.

Transition to Ovid Therapeutics

In 2019, Jason transitioned to Ovid Therapeutics as the Chief Commercial Officer, where he designed the company’s global commercial strategy and launch plan. He was later promoted to Chief Operating Officer, managing the day-to-day execution of strategic goals and spearheading commercial functions until July 2024.

Achievements and Contributions

Throughout his career, Jason Tardio has demonstrated a unique ability to drive organizational effectiveness, strategic planning, and culture transformation. His achievements include successful product launches, turnaround initiatives, and fostering talent development. His extensive experience and strategic insight make him a key player in the pharmaceutical and biotechnology sectors.